XenoLight RediJect 2-DeoxyGlucosone (DG) 750 is a fluorescent imaging probe for in vivo targeting of tumors that typically exhibit elevated glucose uptake rate in comparison to surrounding tissues. To achieve maximum glucose targeting and enhanced tumor uptake, the probe has been designed to contain four 2-DG molecules per dye molecule.
RediJect 2-DG fluorescent imaging probe Standard Kit:
· Novel ready-to-use probe to monitor glucose uptake in vivo non-invasively
· Dispensed to image 20 animals
· Maximum glucose targeting and enhanced tumor uptake
· In vivo imaging quality, validated on IVIS imaging systems
For laboratory use only. This product is intended for animal research only and not for use in humans.